MG
Meditor Group Ltd
Concentrated strategySector-focusedLong-term holder
Total reported value
$48.1M
Reporting period: 2024-09-30 · Number of holdings: 4
Meditor Group Ltd disclosed 4 holdings in its latest 13F filing for the period ending 2024-09-30, with total reported value of $48.1M and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 100
- Diversification
- 8
- Sizing Uniformity
- 87.03
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | EXEL | Exelixis INC | Stock-Healthcare | 73.43% | — | -22.28% | |
| 2 | ESPR | Esperion Therapeutics INC | Stock-Other | 12.99% | — | — | |
| 3 | INDA | Ishares Msci India ETF | ETF-Other | 7.22% | — | — | |
| 4 | EPI | Wisdomtree India Earnings | ETF-Other | 6.36% | — | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2024-09-30 | 4 | $48.1M | 0 | |
| 2024-06-30 | 4 | $54.1M | 0 | |
| 2024-03-31 | 4 | $68.0M | 0 | |
| 2023-12-31 | 4 | $80.0M | 0 | |
| 2023-09-30 | 4 | $77.1M | 0 | |
| 2023-06-30 | 4 | $115.2M | 0 | |
| 2023-03-31 | 4 | $125.5M | 0 | |
| 2022-12-31 | 4 | $147.9M | 0 | |
| 2022-09-30 | 4 | $150.3M | 0 | |
| 2022-06-30 | 4 | $202.2M | 0 | |
| 2022-03-31 | 4 | $239.7M | 0 | |
| 2021-12-31 | 4 | $221.4M | 0 | |
| 2021-09-30 | 4 | $291.1M | 0 | |
| 2021-06-30 | 4 | $282.6M | 100 | |
| 2021-03-31 | 4 | $356.0M | 6 | |
| 2020-12-31 | 5 | $359.4M | 24 | |
| 2020-09-30 | 5 | $446.3M | 12 | |
| 2020-06-30 | 6 | $476.8M | 49 | |
| 2020-03-31 | 6 | $290.4M | 19 | |
| 2019-12-31 | 6 | $350.6M | 28 | |
| 2019-09-30 | 9 | $410.6M | 19 | |
| 2019-06-30 | 9 | $497.2M | 14 | |
| 2019-03-31 | 9 | $533.3M | 16 | |
| 2018-12-31 | 6 | $485.5M | 12 | |
| 2018-09-30 | 6 | $465.3M | 16 | |
| 2018-06-30 | 6 | $512.0M | 22 | |
| 2018-03-31 | 6 | $635.8M | 31 | |
| 2017-12-31 | 8 | $776.9M | 18 | |
| 2017-09-30 | 8 | $658.7M | 29 | |
| 2017-06-30 | 8 | $664.6M | 19 | |
| 2017-03-31 | 7 | $559.3M | 32 | |
| 2016-12-31 | 5 | $405.2M | 13 | |
| 2016-09-30 | 5 | $361.2M | 38 | |
| 2016-06-30 | 5 | $245.6M | 65 | |
| 2016-03-31 | 3 | $126.1M | 50 | |
| 2015-12-31 | 4 | $209.5M | 12 | |
| 2015-09-30 | 4 | $189.6M | 36 | |
| 2015-06-30 | 3 | $145.0M | 20 | |
| 2015-03-31 | 3 | $119.1M | 23 | |
| 2014-12-31 | 3 | $96.4M | 24 | |
| 2014-09-30 | 3 | $86.2M | 43 | |
| 2014-06-30 | 3 | $133.4M | 7 | |
| 2014-03-31 | 3 | $127.6M | 11 | |
| 2013-12-31 | 3 | $135.3M | 100 | |
| 2013-09-30 | 36 | $709.1M | 53 | |
| 2013-06-30 | 40 | $738.5M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is Meditor Group Ltd and what type of investor is it?
Meditor Group Ltd is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2024-09-30), the firm manages a tracked equity portfolio valued at approximately $48.1M, spread across 4 disclosed positions.
What are Meditor Group Ltd's largest equity positions?
Based on the latest 13F filing, Meditor Group Ltd's top holdings by market value are:
1. Exelixis INC (EXEL) — $35.4M (73.4%)
2. Esperion Therapeutics INC (ESPR) — $6.3M (13.0%)
3. Ishares Msci India ETF (INDA) — $3.5M (7.2%)
4. Wisdomtree India Earnings (EPI) — $3.1M (6.4%)
What changes did Meditor Group Ltd make in its most recent portfolio filing?
No notable portfolio changes were recorded for Meditor Group Ltd in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Meditor Group Ltd focus on?
Meditor Group Ltd is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%